share_log

康哲藥業：翌日披露報表

CMS: Next Day Disclosure Return

香港交易所 ·  Apr 10 07:04
Summary by Moomoo AI
康哲藥業控股有限公司（CMS）於2024年4月10日提交了翌日披露報表，披露了公司股份購回的詳細情況。根據報表，公司在2024年4月2日至4月10日期間，透過香港聯合交易所有限公司（香港聯交所）購回了共計7,150,000股普通股，佔公司已發行股份的0.2916%。其中，4月10日單日購回1,030,000股，每股價格介於HKD 7.36至HKD 7.56之間，當日購回總額為HKD 7,670,420。該系列股份購回行動是根據公司董事會的正式授權及相關上市規則進行的，並且已經履行了所有相關的法律及規定要求。
康哲藥業控股有限公司（CMS）於2024年4月10日提交了翌日披露報表，披露了公司股份購回的詳細情況。根據報表，公司在2024年4月2日至4月10日期間，透過香港聯合交易所有限公司（香港聯交所）購回了共計7,150,000股普通股，佔公司已發行股份的0.2916%。其中，4月10日單日購回1,030,000股，每股價格介於HKD 7.36至HKD 7.56之間，當日購回總額為HKD 7,670,420。該系列股份購回行動是根據公司董事會的正式授權及相關上市規則進行的，並且已經履行了所有相關的法律及規定要求。
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 10, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, between April 2 and April 10, 2024, the company repurchased a total of 7,150,000 shares of ordinary shares through the United Stock Exchange of Hong Kong Limited (HKEx), representing 0.2916% of the issued shares. Of these, 1,030,000 shares were repurchased on the single day of April 10 at a price of HKD 7.36 to HKD 7.56, with a total repurchase amount of HKD 7,670,420 on the same day. The share repurchase was conducted pursuant to an official mandate from the Company's Board of Directors and the relevant listing rules and has complied with all relevant legal and regulatory requirements.
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 10, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, between April 2 and April 10, 2024, the company repurchased a total of 7,150,000 shares of ordinary shares through the United Stock Exchange of Hong Kong Limited (HKEx), representing 0.2916% of the issued shares. Of these, 1,030,000 shares were repurchased on the single day of April 10 at a price of HKD 7.36 to HKD 7.56, with a total repurchase amount of HKD 7,670,420 on the same day. The share repurchase was conducted pursuant to an official mandate from the Company's Board of Directors and the relevant listing rules and has complied with all relevant legal and regulatory requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more